BamSEC and AlphaSense Join Forces
Learn More

K-V Pharmaceutical Co

Formerly NYSE: KV.A

Indentures Filter

EX-4
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-4
from 8-K 19 pages Stockholders’ Agreement of K-V Pharmaceutical Company
12/34/56
EX-4
from SC 13D 4 pages Sixth Amended Joint Chapter 11 Plan of Reorganization for K-V Discovery Solutions, Inc. and Its Affiliated Debtors
12/34/56
EX-4.1
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 14 pages This Security Has Not Been Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), and May Not Be Offered, Sold, Pledged or Otherwise Transferred Except in Accordance With the Following Sentence. by Its Acquisition Hereof or of a Beneficial Interest Herein, the Acquirer (1) Represents That It and Any Account for Which It Is Acting Is a “Qualified Institutional Buyer” (Within the Meaning of Rule 144a Under the Securities Act) and That It Exercises Sole Investment Discretion With Respect to Each Such Account, and (2) Agrees That It Will Not Directly or Indirectly Engage in Any Hedging Transactions Involving This Security Unless in Compliance With the Securities Act, And
12/34/56
EX-4.1
from 8-K 129 pages K-V Pharmaceutical Company and Each of the Guarantors Named Herein and Wilmington Trust Fsb, as Trustee Indenture Dated as of March 17, 2011 $ 225,000,000 Principal Amount 12% Senior Secured Notes Due 2015
12/34/56
EX-4.12
from 10-K 23 pages K-V Pharmaceutical Company Registration Rights Agreement November 17, 2010
12/34/56
EX-4.11
from 10-K 13 pages K-V Pharmaceutical Company Stock Purchase Warrant
12/34/56
EX-4.10
from 10-K 13 pages K-V Pharmaceutical Company Stock Purchase Warrant
12/34/56
EX-4.7
from 10-K 38 pages Pledge and Security Agreement Dated as of November 17, 2010 Between Each of the Grantors Party Hereto and U.S. Healthcare I, L.L.C., as Collateral Agent
12/34/56
EX-4.(G)
from 10-K >50 pages Indenture or similar
12/34/56
EX-4.(R)
from 10-K ~5 pages Indenture or similar
12/34/56
EX-4.(Q)
from 10-K ~5 pages Indenture or similar
12/34/56
EX-4.(N)
from 10-K ~10 pages Indenture or similar
12/34/56
EX-4.(M)
from 10-K ~5 pages Indenture or similar
12/34/56
EX-4.(N)
from S-3 1 page Bylaws of the Company
12/34/56
EX-4.2
from 8-K ~20 pages Indenture or similar
12/34/56
EX-4.1
from 8-K >50 pages Indenture or similar
12/34/56
EX-4.(L)
from S-3 1 page Amendment to Bylaws
12/34/56
EX-4.(K)
from S-3 1 page Amendment to Bylaws
12/34/56